199 related articles for article (PubMed ID: 11312664)
1. Virion-associated HIV-1 Vpr: variable amount in virus particles derived from cells upon virus infection or proviral DNA transfection.
Singh SP; Tungaturthi P; Cartas M; Tomkowicz B; Rizvi TA; Khan SA; Kalyanaraman VS; Srinivasan A
Virology; 2001 Apr; 283(1):78-83. PubMed ID: 11312664
[TBL] [Abstract][Full Text] [Related]
2. A novel Vpr peptide interactor fused to integrase (IN) restores integration activity to IN-defective HIV-1 virions.
Kulkosky J; BouHamdan M; Geist A; Pomerantz RJ
Virology; 1999 Mar; 255(1):77-85. PubMed ID: 10049823
[TBL] [Abstract][Full Text] [Related]
3. Epitope-tagging approach to determine the stoichiometry of the structural and nonstructural proteins in the virus particles: amount of Vpr in relation to Gag in HIV-1.
Singh SP; Lai D; Cartas M; Serio D; Murali R; Kalyanaraman VS; Srinivasan A
Virology; 2000 Mar; 268(2):364-71. PubMed ID: 10704344
[TBL] [Abstract][Full Text] [Related]
4. Incorporation of Vpr into human immunodeficiency virus type 1: role of conserved regions within the P6 domain of Pr55gag.
Checroune F; Yao XJ; Göttlinger HG; Bergeron D; Cohen EA
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):1-7. PubMed ID: 7648278
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus type 1 vpr protein transactivation function: mechanism and identification of domains involved.
Forget J; Yao XJ; Mercier J; Cohen EA
J Mol Biol; 1998 Dec; 284(4):915-23. PubMed ID: 9837715
[TBL] [Abstract][Full Text] [Related]
7. Protein stability influences human immunodeficiency virus type 2 Vpr virion incorporation and cell cycle effect.
Kewalramani VN; Park CS; Gallombardo PA; Emerman M
Virology; 1996 Apr; 218(2):326-34. PubMed ID: 8610459
[TBL] [Abstract][Full Text] [Related]
8. Role of the conserved dipeptide Gly75 and Cys76 on HIV-1 Vpr function.
Mahalingam S; Collman RG; Patel M; Monken CE; Srinivasan A
Virology; 1995 Jul; 210(2):495-500. PubMed ID: 7618286
[TBL] [Abstract][Full Text] [Related]
9. Amino acid sequence requirements for the incorporation of the Vpx protein of simian immunodeficiency virus into virion particles.
Park IW; Sodroski J
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):506-10. PubMed ID: 8548329
[TBL] [Abstract][Full Text] [Related]
10. The carboxy-terminal domain is essential for stability and not for virion incorporation of HIV-1 Vpr into virus particles.
Mahalingam S; Patel M; Collman RG; Srinivasan A
Virology; 1995 Dec; 214(2):647-52. PubMed ID: 8553570
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 Vpr-chloramphenicol acetyltransferase fusion proteins: sequence requirement for virion incorporation and analysis of antiviral effect.
Yao XJ; Kobinger G; Dandache S; Rougeau N; Cohen E
Gene Ther; 1999 Sep; 6(9):1590-9. PubMed ID: 10490769
[TBL] [Abstract][Full Text] [Related]
12. Focal glomerulosclerosis in proviral and c-fms transgenic mice links Vpr expression to HIV-associated nephropathy.
Dickie P; Roberts A; Uwiera R; Witmer J; Sharma K; Kopp JB
Virology; 2004 Apr; 322(1):69-81. PubMed ID: 15063118
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 Vpr transactivates LTR-directed expression through sequences present within -278 to -176 and increases virus replication in vitro.
Vanitharani R; Mahalingam S; Rafaeli Y; Singh SP; Srinivasan A; Weiner DB; Ayyavoo V
Virology; 2001 Oct; 289(2):334-42. PubMed ID: 11689055
[TBL] [Abstract][Full Text] [Related]
14. Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles.
Lavallée C; Yao XJ; Ladha A; Göttlinger H; Haseltine WA; Cohen EA
J Virol; 1994 Mar; 68(3):1926-34. PubMed ID: 8107252
[TBL] [Abstract][Full Text] [Related]
15. Structure-functional analysis of human immunodeficiency virus type 1 (HIV-1) Vpr: role of leucine residues on Vpr-mediated transactivation and virus replication.
Thotala D; Schafer EA; Tungaturthi PK; Majumder B; Janket ML; Wagner M; Srinivasan A; Watkins S; Ayyavoo V
Virology; 2004 Oct; 328(1):89-100. PubMed ID: 15380361
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 Vpr regulates expression of beta chemokines in human primary lymphocytes and macrophages.
Muthumani K; Kudchodkar S; Papasavvas E; Montaner LJ; Weiner DB; Ayyavoo V
J Leukoc Biol; 2000 Sep; 68(3):366-72. PubMed ID: 10985253
[TBL] [Abstract][Full Text] [Related]
17. Extent of incorporation of HIV-1 Vpr into the virus particles is flexible and can be modulated by expression level in cells.
Lai D; Singh SP; Cartas M; Murali R; Kalyanaraman VS; Srinivasan A
FEBS Lett; 2000 Mar; 469(2-3):191-5. PubMed ID: 10713269
[TBL] [Abstract][Full Text] [Related]
18. Evidence for direct association of Vpr and matrix protein p17 within the HIV-1 virion.
Sato A; Yoshimoto J; Isaka Y; Miki S; Suyama A; Adachi A; Hayami M; Fujiwara T; Yoshie O
Virology; 1996 Jun; 220(1):208-12. PubMed ID: 8659115
[TBL] [Abstract][Full Text] [Related]
19. Hypophosphorylation of poly(A) polymerase and increased polyadenylation activity are associated with human immunodeficiency virus type 1 Vpr expression.
Mouland AJ; Coady M; Yao XJ; Cohen EA
Virology; 2002 Jan; 292(2):321-30. PubMed ID: 11878934
[TBL] [Abstract][Full Text] [Related]
20. Arginine residues in the C-terminus of HIV-1 Vpr are important for nuclear localization and cell cycle arrest.
Zhou Y; Lu Y; Ratner L
Virology; 1998 Mar; 242(2):414-24. PubMed ID: 9514978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
